Apotex receives Health Canada approval for a generic Ozempic equivalent

Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026

Cirius Therapeutics introduces gestational diabetes initiative

Boehringer Ingelheim's survodutide phase 3 data show significant weight loss in obesity trial

AOTI reports strong real-world outcomes for TWO2 wound therapy

Ascletis completes enrolment for US Phase II study of ASC30 in diabetes

Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children

EKF Diagnostics acquires Beep Insights technology to expand sports performance offering

Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval

Lupin's Dapagliflozin Tablets launched in US market

Eli Lilly launches Foundayo weight‑loss pill in the US

Lupin's Dapagliflozin Tablets receive US regulatory approval

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Lilly's Foundayo (orforglipron) weight loss pill gains US FDA approval